Synthetic Hormones Market: Introduction

  • Synthetic hormones are man-made hormones produced in a laboratory and are similar to hormones produced by human body
  • Synthetic hormones are used to treat men or women with hormonal imbalance. Most commonly, these are used for oral contraception, in agriculture, and in hormone replacement therapy.
  • These hormones are highly active, even at very low concentrations, and the prolonged use of synthetic hormones has been linked to various side effects

Key Drivers and Restrains of Global Synthetic Hormones Market

  • According to the American Thyroid Association (ATA), over 12% of the U.S. population will have some kind of thyroid condition in their lifetime, and nearly 20 million people have been identified to have some kind of thyroid disorders. Hence, rise in prevalence of thyroid-related diseases is projected to fuel the growth of the global market during the forecast period.
  • According to the National Center for Biotechnology Information (NCBI), around 1.2 billion women in the world will be going through menopausal or have postmenopausal symptoms. Symptoms of menopause include vasomotor symptoms such as hot flashes and/or night sweats (also known as VMS), vaginal dryness, and sleep disturbance. Rise in prevalence of menopause is anticipated to drive the global synthetic hormones market.

Are you a Start-up willing to make it Big in the Business? Grab an Exclusive PDF Brochure of Synthetic Hormones Market Report

  • Increase in research & development of new products by manufacturers is expected to fuel the growth of the global synthetic hormone market. In December 2019, Lyndra Therapeutics, Inc. finished pre-clinical trials for its contraceptive pill. This pill is made up of gelatin capsules, which produces a polymer when ingested and delivers the synthetic hormones for three weeks to prevent pregnancy.
  • The cost involved in hormonal replacement therapy (HRT) is quite high. Moreover, patients prefer oral route of administration compared to vaginal. According to NCBI, minimum of 18 tablets of vagifem are required in a month, which costs around US$ 400 to US$ 500, while the cost of Paroxetine, which is consumed orally, is US$ 50 to US$ 100 monthly. Hence, high cost hampers the growth of the global synthetic hormones market.

North America to Lead Global Synthetic Hormones Market

  • In terms of region, the global synthetic hormones market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • According to the NCBI, the prevalence of VMS in the U.S. is estimated at 40 million to 50 million women. Around 23 million women aged between 45 and 55 experience symptoms of menopause such as irregular or heavy bleeding, vaginal dryness, and hot flashes. High occurrence of menopause and its symptoms in North America is projected to drive the synthetic hormones market in the region.
  • According to the European Society of Endocrinology, diseases associated with thyroid are the most common type of endocrine disorders. The autoimmune thyroid disease is the most commonly occurring autoimmune diseases in women of conceptive age, whereas thyroid cancer in the same age group of women is the second most prevailing cancer. Hence, Europe is the second major market for synthetic hormones.
  • The market in Asia Pacific is expected to expand at the highest CAGR during the forecast period, due to increase in health care expenditure, surge in population, and rise in customer awareness. The Government of India is taking initiatives to control the population by endorsing contraceptive pills. This is expected to boost the growth of the synthetic hormones market in the region.
  • Latin America and Middle East & Africa are anticipated to be lucrative markets for synthetic hormones during the forecast period due to increase in health awareness.

Stuck in a Neck-to-Neck Competition with Other Brands? Request a Custom Report on “Synthetic Hormones Market” here

Key Manufacturers Operating in Global Synthetic Hormones Market

Key manufacturers operating in the global market are:

  • Pfizer, Inc.
  • McGuff Pharmaceuticals, Inc.
  • Lyndra Therapeutics, Inc.
  • Ferring B.V.
  • Slayback Pharma
  • American Regent, Inc.
  • Endo International plc
  • IBSA Institut Biochimique SA
  • Acerus Pharmaceuticals Corporation
  • Lupin Pharmaceuticals, Inc.

Global Synthetic Hormones Market: Research Scope

Global Synthetic Hormones Market, by Product Type

  • Steroid Hormones
  • Peptide Hormone
  • Amino Acid Derivatives
  • Others

Global Synthetic Hormones Market, by Route of administration

  • Oral
  • Topical
  • Nasal
  • Intravenous
  • Suppository

Global Synthetic Hormones Market, by End-user

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Synthetic Hormones Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market

Note:Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Synthetic Hormones Market

Pre Book